On Jan. 25, 2021, Mateon Therapeutics announced that it was launching its mobile app, ARTIHealthTM, for respiratory health assessment, in India along with its COVID-19 therapeutic, PulmoHealTM also known as ARTIVedaTM, for total care of COVID-19 patients.

Initially, the drug and device combination was distributed in India through Indian partner, Windlas Biotech, where both drug and device will be marketed under the brand name PulmoHealTM.